- The 8 States Most Likely to Legalize Marijuana Next
- BlackBerry Is Finally Realizing Smartphones Aren't the Answer
- Express Scripts and AbbVie Drug-Pricing Deal Might Devastate Biotech Bull Market
- Dow 18,000: Why This Market Rally May Never Happen Again
- Gilead Sciences Is Not a Buy; It's Heading Lower on Price War: Jim Cramer
Here are two generic-drug companies that should hold up well, regardless of the current uncertainty.
This Editor's Choice piece discusses two solid logistics names.
This Editor's Choice piece discusses trucking stocks Arkansas Best and Swift Transportation.
They may be selling at rock-bottom valuations, but that's no reason to jump in.
This Editor's Choice piece discusses avoiding or shorting a couple of recent IPOs.
This Editor's Choice piece discusses two small-cap energy stocks with good growth prospects.
They're selling at bargain prices, and macroeconomic factors are in their favor.
This Editor's Choice piece discusses two cheap, cash-rich companies.
Barrick Gold and Newmont Mining are cheap stocks with solid dividend yields.
This Editor's Choice piece discusses Valero Energy and Phillips 66.